B. Riley Reaffirms Neutral Rating for Heska Corp.

B. Riley Reaffirms Neutral Rating for Heska Corp.


's stock had its "neutral" rating reissued by equities research analysts at B. Riley in a note issued to investors on Wednesday. They presently have a $53.00 target price on the stock.



from Biotech News